Insights

Research and Clinical Trial Topics

Cough as an Endpoint in IPF Trials: Why it Matters

Cough as an Endpoint in IPF Trials: Why it Matters

Increased importance has been placed in recent years on the ability of idiopathic pulmonary fibrosis (IPF) treatments to impact how patients feel and function, beyond survival (Raghu, et al., 2024). In IPF, one of the most burdensome symptoms impacting how patients...

read more

Healthcare and Remote Patient Monitoring Topics

Subscribe

Get notified whenever we publish a new blog, video or whitepaper